GLP-1 medications, such as Ozempic and Wegovy, are showing notable influence beyond weight loss, significantly transforming consumer behavior and impacting multiple industries. According to CivicScience’s GLP-1 Consumer Tracker, which gathered insights from 118,000 users, these drugs are not only reducing users’ appetite but also shaping their lifestyle habits. Users are snacking less, opting for healthier food choices, and reducing alcohol consumption, while showing increased interest in regular exercise and mental health services. Furthermore, with over half of GLP-1 users changing dining habits by eating out less and choosing smaller portions, brands are beginning to adapt. For instance, Nestlé’s new Vital Pursuit frozen food line targets the rising demand for healthier, portion-controlled meals among this demographic. Additionally, mental health support services are increasingly in demand among GLP-1 users, as emotional well-being has declined slightly, indicating a potential need for accessible support resources. Advertisers can leverage these insights to help local businesses reach GLP-1 users and align campaigns with the current focus on health, wellness, and mindful consumption habits.
***Opportunity:
Grocery Stores, Health Food Retailers, Fitness Centers, Mental Health Clinics, Vitamin and Supplement Stores, Wellness App Developers, Convenience Stores, Restaurants
